These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27454027)

  • 1. Evolution of novel therapeutic options for pancreatic cancer.
    Saluja AK; Dudeja V; Banerjee S
    Curr Opin Gastroenterol; 2016 Sep; 32(5):401-407. PubMed ID: 27454027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Therapies for Pancreatic Cancer and Hurdles Ahead.
    Aslan M; Shahbazi R; Ulubayram K; Ozpolat B
    Anticancer Res; 2018 Dec; 38(12):6591-6606. PubMed ID: 30504367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer: medical management (novel chemotherapeutics).
    Páez D; Labonte MJ; Lenz HJ
    Gastroenterol Clin North Am; 2012 Mar; 41(1):189-209. PubMed ID: 22341258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Perspectives on Novel Drug Carrier Systems and Therapies for Management of Pancreatic Cancer: An Updated Inclusive Review.
    Bhosale RR; Gangadharappa HV; Gowda DV; Osmani RAMA; Vaghela R; Kulkarni PK; Sairam KV; Gurupadayya B
    Crit Rev Ther Drug Carrier Syst; 2018; 35(3):195-292. PubMed ID: 29953347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer: Stroma and its current and emerging targeted therapies.
    Kota J; Hancock J; Kwon J; Korc M
    Cancer Lett; 2017 Apr; 391():38-49. PubMed ID: 28093284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.
    Teague A; Lim KH; Wang-Gillam A
    Ther Adv Med Oncol; 2015 Mar; 7(2):68-84. PubMed ID: 25755680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
    Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
    Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
    J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current standards and new innovative approaches for treatment of pancreatic cancer.
    Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
    Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced or metastatic pancreatic cancer: molecular targeted therapies.
    Bayraktar S; Rocha-Lima CM
    Mt Sinai J Med; 2010; 77(6):606-19. PubMed ID: 21105124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and adjuvant therapy for patients with pancreatic carcinoma.
    Clark JW; Glicksman AS; Wanebo HJ
    Cancer; 1996 Aug; 78(3 Suppl):688-93. PubMed ID: 8681308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.